Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Pharma
Rhythm's Imcivree bags FDA nod for brain-damage related obesity
The new FDA nod makes Rhythm Pharma's Imcivree the first approved drug for acquired hypothalamic obesity.
Zoey Becker
Mar 20, 2026 11:05am
Novo scores FDA nod for Wegovy HD, plans April launch
Mar 19, 2026 2:11pm
Rhythm's Imcivree posts ph. 3 miss in rare genetic obesities
Mar 17, 2026 11:43am
Lilly telegraphs $126M Japan production expansion
Mar 12, 2026 11:41am
Lilly warns of 'impurity' in some compounded tirzepatide drugs
Mar 12, 2026 10:00am
China signs off on Pfizer, Sciwind's GLP-1 weight loss drug
Mar 6, 2026 11:22am
